SEARCH HEALTH CONDITIONS BY ALPHABETS
Hyperparathyroidism Secondary to Renal Impairment
Medications for Hyperparathyroidism Secondary to Renal Impairment
About Hyperparathyroidism Secondary to Renal Impairment: Hyperparathyroidism Secondary to Renal Impairment is the excessive production of parathyroid hormone from the adrenal glands as a result of decreased renal function. In impairment there`s a drop in conversion to calcitriol which contributes reduction of calcium absorption and so hypocalcemia, this in turn causes an increases the parathyroid hormone levels. Erosion that brought to bone fractures is caused by high hormone levels.
Drugs Used to Treat Hyperparathyroidism Secondary to Renal Impairment
This list of medications have been somehow associated with, or found at the treating this illness.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Parsabiv | Rx | N | Insert review | 0.0 | |||
Generic name: etelcalcetide systemic Drug course: calcimimetics For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| calcifediol | Rx | C | N | 7 testimonials | 7.5 | ||
Generic name: calcifediol systemic Brand name: Rayaldee Medicine class: vitamins For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph | |||||||
| Rayaldee | Rx | C | N | 7 testimonials | 7.5 | ||
Generic name: calcifediol systemic Medicine class: vitamins For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| etelcalcetide | Rx | N | Insert review | 0.0 | |||
Generic name: etelcalcetide systemic Brand name: Parsabiv Drug course: calcimimetics For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Prizes | This medication might not be approved by the FDA for treating this illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal reproduction studies have demonstrated an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in elderly women obviously outweigh potential rewards. |
| N | FDA has not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| Inch | features a high potential for abuse. Has no accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
| Two | features a high potential for abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may lead to acute physical or psychological dependence. |
| 3 | Has a potential for abuse less than individuals in schedules 1 and 2 2. Features a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | features a minimal potential for abuse relative to individuals in schedule 3. It`s a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | features a minimal potential for abuse relative to individuals in schedule 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always seek advice from your physician to make sure the information applies to your circumstances.
- Hydatid Disease
- Hymenolepiasis
- Hyperacousis
- Hyperacusis
- Hyperammonemia
- Hypercalcemia of Malignancy
- Hypercalciuria
- Hyperekplexia
- Hyperemesis Diet
- Hyperemesis Gravidarum with Metabolic Disturbance
- Hyperexplexia
- Hyperhomocysteinemia
- Hyperhomocystenemia
- Hyperimmunoglobulin D Periodic Fever Syndrome
- Hyperimmunoglobulin D Syndrome
- Hyperkalemic Periodic Paralysis
- Hyperkinetic Syndrome of Childhood
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated Beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL
- Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
- Hyperlipoproteinemia, Fredrickson Type IIa
- Hyperlipoproteinemia, Fredrickson Type IIb
- Hyperlipoproteinemia, Fredrickson Type III
- Hyperlipoproteinemia, Fredrickson Type IV
- Hyperlipoproteinemia, Fredrickson Type V
- Hyperparathyroidism Secondary to Renal Impairment
- Hyperphosphatemia
- Hyperphosphatemia of Renal Failure
- Hyperprolactinemia
- Hypersecretory Conditions
- Hypersensitivity Vasculitis
- Hypersexuality State
- Hypersomnia
- Hypertensive Congestive Heart Failure
- Hypertensive Encephalopathy
- Hypertensive Heart Disease
- Hypertensive Heart with CHF and Renal Disease
- Hypertensive Heart Without CHF and Renal Disease
- Hypertensive Renal Disease
- Hypertensive Retinopathy
- Hypertensive Urgency
- Hyperuricemia Secondary to Chemotherapy
- Hypervitaminosis A
- Hypervitaminosis D
- Hypodermoclysis
- Hypoestrogenism
- Hypokalemic Periodic Paralysis
- Hypoparathyroidism
- Hypophosphatasia
- Hypoproteinemia
- Hypoprothrombinemia
- Hypoprothrombinemia, Anticoagulant Induced
- Hypoprothrombinemia, Not Associated with Anticoagulant Therapy
- Hypoprothrombinemia, Prophylaxis
- Hypotension Secondary to Hemodialysis
- Hypotrichosis of Eyelashes
- Hypoventilation
- Hypovolemia
- Hysterosalpingography
Top USA Pharma Companies
Product Categories
Popular Categories
Health Condition
- Hydatid Disease
- Hymenolepiasis
- Hyperacousis
- Hyperacusis
- Hyperammonemia
- Hypercalcemia of Malignancy
- Hypercalciuria
- Hyperekplexia
- Hyperemesis Diet
- Hyperemesis Gravidarum with Metabolic Disturbance
- Hyperexplexia
- Hyperhomocysteinemia
- Hyperhomocystenemia
- Hyperimmunoglobulin D Periodic Fever Syndrome
- Hyperimmunoglobulin D Syndrome
- Hyperkalemic Periodic Paralysis
- Hyperkinetic Syndrome of Childhood
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated Beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL
- Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
- Hyperlipoproteinemia, Fredrickson Type IIa
- Hyperlipoproteinemia, Fredrickson Type IIb
- Hyperlipoproteinemia, Fredrickson Type III
- Hyperlipoproteinemia, Fredrickson Type IV
- Hyperlipoproteinemia, Fredrickson Type V
- Hyperparathyroidism Secondary to Renal Impairment
- Hyperphosphatemia
- Hyperphosphatemia of Renal Failure
- Hyperprolactinemia
- Hypersecretory Conditions
- Hypersensitivity Vasculitis
- Hypersexuality State
- Hypersomnia
- Hypertensive Congestive Heart Failure
- Hypertensive Encephalopathy
- Hypertensive Heart Disease
- Hypertensive Heart with CHF and Renal Disease
- Hypertensive Heart Without CHF and Renal Disease
- Hypertensive Renal Disease
- Hypertensive Retinopathy
- Hypertensive Urgency
- Hyperuricemia Secondary to Chemotherapy
- Hypervitaminosis A
- Hypervitaminosis D
- Hypodermoclysis
- Hypoestrogenism
- Hypokalemic Periodic Paralysis
- Hypoparathyroidism
- Hypophosphatasia
- Hypoproteinemia
- Hypoprothrombinemia
- Hypoprothrombinemia, Anticoagulant Induced
- Hypoprothrombinemia, Not Associated with Anticoagulant Therapy
- Hypoprothrombinemia, Prophylaxis
- Hypotension Secondary to Hemodialysis
- Hypotrichosis of Eyelashes
- Hypoventilation
- Hypovolemia
- Hysterosalpingography
Easily find an affordable health insurance plan
